| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |